Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:09

Coagulation

11.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.0K
Coagulation01:06

Coagulation

1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.5K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

5.7K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.7K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced organ protection strategies in aortic arch surgery: A narrative review.

Perfusion·2026
Same author

Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score-Matched Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Evaluating a Novel Cell-Free Preservation Solution for Human Cardiomyocyte Protection: A Proof-of-Concept Study.

BioMed research international·2026
Same author

Congestion, but not low cardiac output, is independently associated with acute kidney injury following contrast agent exposure.

Frontiers in cardiovascular medicine·2026
Same author

Vitamin K-dependent proteins in patients undergoing head and neck free flap surgery - a prospective observational study.

Scandinavian journal of clinical and laboratory investigation·2026
Same author

Factors associated with Gla-rich protein serum concentrations in healthy adults.

Biochemia medica·2026

Related Experiment Video

Updated: Feb 19, 2026

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

2.1K

Coagulation meets calcification: the vitamin K system.

Thilo Krueger1, Ralf Westenfeld, Leon Schurgers

  • 1Department of Nephrology and Clinical Immunology, University Hospital of the RWTH Aachen, Aachen - Germany.

The International Journal of Artificial Organs
|April 14, 2009
PubMed
Summary

Vitamin K deficiency worsens bone and vascular disease in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients. Supplementation may help mitigate these risks, particularly concerning vascular calcification.

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.4K

Related Experiment Videos

Last Updated: Feb 19, 2026

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

2.1K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.4K

Area of Science:

  • Nephrology
  • Biochemistry
  • Vascular Biology

Background:

  • Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) face significantly higher morbidity and mortality.
  • Bone disease (renal osteodystrophy) and vascular disease (accelerated arteriosclerosis) are key contributors to poor outcomes in these patients.
  • Vitamin K-dependent proteins, such as osteocalcin and matrix Gla protein (MGP), are crucial for bone mineralization and preventing vascular calcification.

Purpose of the Study:

  • To summarize data on the role of vitamin K deficiency and supplementation in bone and vascular disease within CKD and ESRD populations.
  • To explore the potential risks associated with vitamin K antagonists in CKD patients with pre-existing vascular calcification.

Main Methods:

  • Review of existing data and literature concerning vitamin K metabolism and its impact on bone and vascular health in kidney disease.
  • Analysis of the physiological roles of osteocalcin and MGP in mineralization and calcification processes.
  • Consideration of the implications of vitamin K deficiency and antagonist use in the context of CKD/ESRD.

Main Results:

  • Vitamin K deficiency impairs the function of osteocalcin and MGP, potentially leading to bone demineralization and vascular calcification.
  • This impairment contributes to the 'calcification paradox' observed in CKD/ESRD patients.
  • Long-term use of vitamin K antagonists may pose risks, especially in CKD patients with substantial vascular calcification.

Conclusions:

  • Vitamin K plays a critical role in maintaining bone and vascular health, particularly in patients with kidney disease.
  • Vitamin K deficiency is implicated in the pathogenesis of renal osteodystrophy and accelerated arteriosclerosis.
  • Further research into vitamin K supplementation strategies for CKD/ESRD patients is warranted to address bone and vascular complications.